DanCann Pharma A/S: Future strategic direction
COPENHAGEN, Denmark, 26 October 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby provides detailed comments on its new strategic direction through a comprehensive press release.Introduction: The DanCann Pharma 2023-2025 focus Historically, the Company had a broad approach within the market for cannabinoids, involving various aspects of the value chain, including cultivation, production, harvesting of raw materials, and packaging, as well as the sale and distribution of final products.